SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ZymoGenetics, Inc. and Bristol-Myers Squibb Company to Present PEG-Interferon Lambda Phase 2a Interim Clinical Trial Results at AASLD 2010